Botox has gained popularity for a variety of medical purposes over the years. While many people use it widely, some individuals worry about side effects like headaches. Knowing more about the link ...

It began as an odd observation among plastic surgery patients, and ended up as an FDA approved drug — on Friday, the agency green-lighted the use of Botox, a popular wrinkle-reducing procedure, to ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

NEW YORK (Reuters) - Regulators seem inclined to approve Allergan Inc's wrinkle drug Botox to prevent migraine headaches in millions of Americans, industry analysts said, based on information the ...

Just a few weeks after paying a $600 million to fine settle criminal charges that Botox was illegally marketed to treat headaches, Allergan (AGN) has won FDA approval to promote the med for treating ...

Most migraine management is off-label, doctors say. Sept. 10, 2010 -- Migraine sufferers like Barbara Trupin, who endured the severe headaches weekly for almost 20 years, will often do anything to get ...

Q. I’ve been having migraines for so long that I finally decided I want to try Botox. I’m 28 and I want to do the treatment but I want to make sure that I don’t get weird side effects that make me ...

If you live with chronic migraine, you know how hard it can be to catch a break. And when you’re navigating frequent attacks ...

Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

Botox was first approved for the treatment of chronic migraine in 2010, with the recommended dosage given every 12 weeks. I first started Botox many years ago, when I shifted from an episodic to a ...

Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of ...